PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'International Vaccine Institute, Seoul, Republic of Korea. jerome.kim@ivi.int.\', \'International Vaccine Institute, Seoul, Republic of Korea.\', \'Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge, UK.\', \'University of Antananarivo, Antananarivo, Madagascar.\', \'International Centre for Diarrheal Diseases Research, Dhaka, Dhaka, Bangladesh.\', \'UCLA Fielding School of Public Health, Los Angeles, CA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41591-021-01230-y
?:hasPublicationType
?:journal
  • Nature medicine
is ?:pmid of
?:pmid
?:pmid
  • 33469205
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 17.067
?:rankingScore_hIndex
  • 484
?:title
  • Looking beyond COVID-19 vaccine phase 3 trials.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33469205>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33469205>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all